ClinicalTrials.gg
Drug

Hetrombopag clinical trials

Also written SHR8735.

Includes 24 studies of Hetrombopag olamine.

studies test it
53
open now
24
in phase 3
13
first study started
2012

How each study uses hetrombopag is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the hetrombopag studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Hetrombopag
19
Herombopag
6

Development codes

SHR8735
2

Studies by the year they started

53 studies that test it; most in 2022 (10)

Studies that test hetrombopag, by start year
YearStudies
20121
20142
20151
20171
20182
20194
20203
20215
202210
20238
20245
20257
20264

By phase

A phase 1/2 study counts in both.

Phase 1
14
Phase 2
24
Phase 3
13
Phase 4
2
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 23 · Other 30

Jiangsu HengRui Medicine Co., Ltd. (22) · Institute of Hematology & Blood Diseases Hospital, China (4) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (4) · Peking Union Medical College Hospital (3) · Henan Cancer Hospital (2) · Sun Yat-sen University (2) · Fujian Cancer Hospital (2) · Atridia Pty Ltd. (1)

Often tested with

Tested in the same studies.

Recombinant human thrombopoietin (2) · Aspirin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 9, 1 in phase 3

Studies that test hetrombopag, phase 3 first.

Studies

Open first, then newest update. How each study uses hetrombopag is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 53

See all 53 studies that test hetrombopag →

Given beside what is tested · 1 — hetrombopag is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call hetrombopag · ClinicalTrials.gg INT000612

  • MeSH (NLM) C000614661hetrombopagConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 9WGT51BDDLRAFUTROMBOPAGConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.